本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Mirum Pharmaceuticals, Inc.

91.83
-6.9900-7.07%
盤後91.830.00000.00%19:30 EDT
成交量:179.80萬
成交額:1.66億
市值:59.63億
市盈率:-6.52
高:98.76
開:98.76
低:91.73
收:98.82
52周最高:130.00
52周最低:63.23
股本:6,493.22萬
流通股本:5,641.51萬
量比:2.36
換手率:3.19%
股息:- -
股息率:- -
每股收益(TTM):-14.0800
每股收益(LYR):-0.4700
淨資產收益率:-702.97%
總資產收益率:-6.79%
市淨率:-572.13
市盈率(LYR):-195.38

資料載入中...

2020/04/29

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2020/03/12

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2020/03/12

重要事件披露

Current report, items 2.02 and 9.01
2020/02/14

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/13

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/17

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2020/01/14

重要事件披露

Current report, items 5.02, 8.01, and 9.01
2020/01/06

SEC問詢函

[Cover]Correspondence
2020/01/06

SEC問詢函

[Cover]Correspondence
2020/01/06

招股説明書

General form for registration of securities under the Securities Act of 1933
2019/12/27

重要事件披露

Current report, items 5.02 and 9.01
2019/12/16

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2019/11/06

季度報告

Quarterly report [Sections 13 or 15(d)]
2019/11/06

重要事件披露

Current report, items 2.02 and 9.01
2019/09/10

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2019/08/28

季度報告

Quarterly report [Sections 13 or 15(d)]
2019/08/28

員工持股計劃

Securities to be offered to employees in employee benefit plans
2019/08/28

重要事件披露

Current report, items 2.02 and 9.01
2019/08/01

超過5%披露

General statement of acquisition of beneficial ownership
2019/07/30

超過5%披露

General statement of acquisition of beneficial ownership